Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neuphoria Therapeutics (NEUP) Other Non Operating Income (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Other Non Operating Income for 2 consecutive years, with -$135659.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 121.55% to -$135659.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$307172.0, a N/A change, with the full-year FY2025 number at $239686.0, down 89.14% from a year prior.
  • Other Non Operating Income was -$135659.0 for Q4 2025 at Neuphoria Therapeutics, down from -$61735.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $866900.0 in Q2 2025 to a low of -$976678.0 in Q1 2025.